Response to recombinant human erythropoietin (rHu-Epo) in a patient with chronic renal failure and myelomonocytic leukaemia

Nephrol Dial Transplant. 2001 Jan;16(1):191-2. doi: 10.1093/ndt/16.1.191.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anemia / drug therapy
  • Anemia / etiology
  • Bone Marrow / pathology
  • Erythropoietin / therapeutic use*
  • Humans
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / drug therapy*
  • Leukemia, Myelomonocytic, Chronic / complications*
  • Leukemia, Myelomonocytic, Chronic / pathology
  • Male
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Erythropoietin